Health Care & Life Sciences » Pharmaceuticals | Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.82
Market Cap
$261.63 M
Shares Outstanding
25.75 M
Public Float
22.79 M

Profile

Address
3650 Gilmore Way
Burnaby British Columbia V5G 4W8
Canada
Employees -
Website http://www.xenon-pharma.com
Updated 07/08/2019
Xenon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in discovering and developing a pipeline of differentiated therapeutics. It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.

Financials

View All
Created with Highcharts 5.0.14Xenon Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.3 8333 83313 01813 01815 75215 75222 99722 99730 70430 70434 49734 497201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Xenon Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.27 35627 35628 37028 37015 57715 5771 8031 80331131158658620132014201520162017201805k10k15k20k25k30k

Simon Neil Pimstone
Chief Executive Officer & Director
Michael M. Tarnow
Chairman